Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Sam Allen About Belluscura plc ( www.belluscura.com ) Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations. Background & history Belluscura was established in the UK in December 2015 with the object of commercialising intellectual property in the medical device space. The Company is currently focused on devices and treatments involving enriched oxygen. The Company has raised approximately $11.7 million since 2018 in a number of fundraising rounds in order to develop and commercialise the Company s product portfolio.
Wireless Device To Monitor Lung Sounds Market Value Predicted To Reach US $8 5 Billion By 2027: Acumen Research And Consulting
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Türkiye de her yıl 100 bin kişi sigaradan dolayı hayatını kaybediyor
dogruhaber.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dogruhaber.com.tr Daily Mail and Mail on Sunday newspapers.
Report proffers a comprehensive outlay of the Smoking Cessation Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the upcoming trends of the Smoking Cessation epidemiology that is going to impact the overall patient pool and the market outlook in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan).
The report covers the Smoking Cessation market trends covering key pharmaceutical companies in the market, upcoming as well as Smoking Cessation marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth.
Peripheral T-cell Lymphoma Market to exhibit a CAGR of 9.46% during the forecast period of 2020-2030, announces DelveInsight
LAS VEGAS, Feb. 2, 2021 /PRNewswire/ DelveInsight s
Peripheral T-Cell Lymphoma (PTCL) Market report provides an absolute comprehension of the PTCL, historical and forecasted epidemiology and the Peripheral T-Cell Lymphoma market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Peripheral T-Cell Lymphoma market report also proffers an analysis of recent Peripheral T-Cell Lymphoma treatment practice/algorithm, market drivers, market barriers and unmet medical needs.
Some of the essential highlights of the
Peripheral T-Cell Lymphoma Market Research Report